- Home
- PKE vs ITOS Comparison
PKE vs ITOS Comparison
Compare PKE & ITOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PKE
- ITOS
- Stock Information
- Founded
- PKE 1954
- ITOS 2011
- Country
- PKE United States
- ITOS United States
- Employees
- PKE N/A
- ITOS N/A
- Industry
- PKE Military/Government/Technical
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PKE Industrials
- ITOS Health Care
- Exchange
- PKE Nasdaq
- ITOS Nasdaq
- Market Cap
- PKE 260.4M
- ITOS 270.7M
- IPO Year
- PKE N/A
- ITOS 2020
- Fundamental
- Price
- PKE $13.45
- ITOS $6.70
- Analyst Decision
- PKE
- ITOS Strong Buy
- Analyst Count
- PKE 0
- ITOS 3
- Target Price
- PKE N/A
- ITOS $25.67
- AVG Volume (30 Days)
- PKE 47.6K
- ITOS 553.7K
- Earning Date
- PKE 05-29-2025
- ITOS 04-28-2025
- Dividend Yield
- PKE 3.74%
- ITOS N/A
- EPS Growth
- PKE N/A
- ITOS N/A
- EPS
- PKE 0.36
- ITOS N/A
- Revenue
- PKE $61,420,000.00
- ITOS $35,000,000.00
- Revenue This Year
- PKE N/A
- ITOS N/A
- Revenue Next Year
- PKE N/A
- ITOS $31.74
- P/E Ratio
- PKE $36.52
- ITOS N/A
- Revenue Growth
- PKE 15.45
- ITOS 177.89
- 52 Week Low
- PKE $11.96
- ITOS $4.80
- 52 Week High
- PKE $15.57
- ITOS $18.75
- Technical
- Relative Strength Index (RSI)
- PKE 55.62
- ITOS 49.45
- Support Level
- PKE $12.91
- ITOS $6.58
- Resistance Level
- PKE $13.43
- ITOS $7.80
- Average True Range (ATR)
- PKE 0.31
- ITOS 0.51
- MACD
- PKE 0.04
- ITOS -0.03
- Stochastic Oscillator
- PKE 85.07
- ITOS 32.10
About PKE Park Aerospace Corp.
Park Aerospace Corp designs develop and manufactures engineered, advanced composite materials and composite structures and assemblies and low-volume tooling for the aerospace markets and prototype tooling for such structures and assemblies. Geographically, the company derives a majority of revenue from North America and also has a presence in a company operates its business in Asia and Europe. It offers advanced composite Prepregs for Aircraft Structures and Interiors, Sigma Strut and Alpha Strut.
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.